Leniroid (alfa / beta versions)

Relief proctologic gel

Treatment for anus rectal disorders causing swelling, inflammation and skin discomfort.

Effective and innovative formulation based on Hyaluronic acid, main ingredient involved in tissue repair processes. It comes in 2 versions: the Leniroid Beta is also enriched with a patented agent, able to restore the function of the skin barrier.

The light, fresh and delicate gel formulation, based on substances with a film-forming action and natural ingredients, offers immediate comfort by performing an excellent lubricating action. 

 The correct level of hydration and the physiological elasticity of the anal mucosa are also restored, reducing and alleviating pain, itching and burning sensations.

Regulatory status

Medical device Class IIa.

Indication

Indicated in anorectal repair processes, such as internal and external hemorrhoids, anal fissures, proctitis and anal itching.

Ideal as a prolonged treatment of chronic symptoms and in cases of:

  • prolapse of the tissues
  • constipation
  • tendency to recurrence

Suitable to prevent anus-rectal discomfort maintaining by physiological tone and elasticity.

Efficacy tests

In vitro test:
barrier effect: -11,4% IL-6

PMCF data:

  • Perianal congestion -61%
  • Itching: -70%
  • Irritation: -72%
  • Burning: -75%
  • Symptons relief 1 week (75%)
  • Side effect: 0%

Aspect

Available in 2 formats:
• 3.5ml single-dose units (10 units pack)
• 30 ml aluminum tube with cannula for internal application

Ingredients

Leniroid is available in 2 versions, which differ for only one ingredient:

Both formulations are enriched with:

  • Hyaluronic acid: moisturizing and lubricating agent, it maintains the correct tissue hydration, playing an essential role in tissues repair processes. 
  • Bisabolol, Metil Sulfonil Metano: soothing and calming effect
  • Triclosan / Tropolone: anti-bacterial effect.

Leniroid Beta is also enriched with:

  • TRI-Solve P® : patented compound based on ceramides and a natural disaccharide (trehalose) with moisturizing and skin repairing activity to foster the reduction of Trans Epidermal Water Loss (TEWL).  

While Leniroid Alfa replaces the patented ingredient with:

  • Trealix:  cosmotropic disaccharide enriched with hydrolyzed proteins, able to keep water molecules making them bio-available whenever needed, with deep hydrating and restorative properties.

Claims

  • With Trisolve P ® - patented filming technology
  • Barrier effect
  • Available also Alfa version with Trealix® instead of Tri-Solve P®
  • Reduces pain, itching and burning
  • Soothing action
  • Healing agent
  • Cortison free

Application

External and/or internal application on clean skin.
Apply two-three times a day, before and/or after each evacuation.
Continue the treatment as needed until symptoms disappear.

Reserved contents

Login to view restricted content
Become distributor